Glypican 3 overexpression in primary and metastatic Wilms tumors

Virchows Archiv

Volumn 466, Issue 1, 2015, Pages 67-76

  Tretiakova, Maria ^a,b   Zynger, Debra L ^c   Luan, Chunyan ^d   Andeen, Nicole K ^b   Finn, Laura S ^b   Kocherginsky, Masha ^e   Teh, Bin T ^f   Yang, Ximing J ^d  

^a UNIVERSITY OF WASHINGTON   (United States)

^b SEATTLE CHILDREN S HOSPITAL   (United States)

^c OHIO STATE UNIVERSITY   (United States)

^d NORTHWESTERN UNIVERSITY   (United States)

^e UNIVERSITY OF CHICAGO   (United States)

^f VAN ANDEL RESEARCH INSTITUTE   (United States)

Author keywords

Glypican 3; GPC3; Wilms tumor

Indexed keywords

GLYPICAN 3; MESSENGER RNA; GLYPICAN; GPC3 PROTEIN, HUMAN; TUMOR MARKER;

ADULT; AGED; ARTICLE; CANCER SURVIVAL; CHILD; CONTROLLED STUDY; CYTOPLASM; DIFFERENTIAL DIAGNOSIS; FEMALE; FETUS; FOLLOW UP; GENE EXPRESSION PROFILING; GENE OVEREXPRESSION; GENE PRODUCT; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; INFANT; KIDNEY CARCINOMA; KIDNEY DEVELOPMENT; KIDNEY TUMOR; MAJOR CLINICAL STUDY; MALE; MESOBLASTIC NEPHROMA; METANEPHRIC ADENOMA; NEPHROBLASTOMA; ONCOCYTOMA; PARTIAL NEPHRECTOMY; PHENOTYPE; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; PROTEIN ANALYSIS; TISSUE MICROARRAY; TUMOR VOLUME; ADENOMA; COMPARATIVE STUDY; GENE EXPRESSION REGULATION; GENETICS; KIDNEY; METABOLISM; MIDDLE AGED; NEWBORN; PATHOLOGY; PRESCHOOL CHILD; RETROSPECTIVE STUDY; SECONDARY;

ADENOMA; ADULT; AGED; CARCINOMA, RENAL CELL; CHILD; CHILD, PRESCHOOL; GENE EXPRESSION REGULATION, NEOPLASTIC; GLYPICANS; HUMANS; INFANT; INFANT, NEWBORN; KIDNEY; KIDNEY NEOPLASMS; MIDDLE AGED; NEPHROMA, MESOBLASTIC; RETROSPECTIVE STUDIES; RNA, MESSENGER; TUMOR MARKERS, BIOLOGICAL; WILMS TUMOR;

EID: 84925487796     PISSN: 09456317     EISSN: 14322307     Source Type: Journal    
DOI: 10.1007/s00428-014-1669-4     Document Type: Article

References (44)

1. Hartwig S, Hu MC, Cella C, Piscione T, Filmus J, Rosenblum ND (2005) Glypican-3 modulates inhibitory BMP2-Smad signaling to control renal development in vivo. Mech Dev 122(7–8):928–938
2. White GR, Kelsey AM, Varley JM, Birch JM (2002) Somatic glypican 3 (GPC3) mutations in Wilms’ tumour. Br J Cancer 86(12):1920–1922
3. Hughes-Benzie RM, Hunter AG, Allanson JE, Mackenzie AE (1992) Simpson-Golabi-Behmel syndrome associated with renal dysplasia and embryonal tumor: localization of the gene to Xqcen-q21. Am J Med Genet 43(1–2):428–435
4. Iglesias BV, Centeno G, Pascuccelli H, Ward F, Peters MG, Filmus J et al (2008) Expression pattern of glypican-3 (GPC3) during human embryonic and fetal development. Histol Histopathol 23(11):1333–1340
5. Pilia G, Hughes-Benzie RM, MacKenzie A, Baybayan P, Chen EY, Huber R et al (1996) Mutations in GPC3, a glypican gene, cause the Simpson-Golabi-Behmel overgrowth syndrome. Nat Genet 12(3):241–247
6. Saikali Z, Sinnett D (2000) Expression of glypican 3 (GPC3) in embryonal tumors. Int J Cancer 89(5):418–422
7. Toretsky JA, Zitomersky NL, Eskenazi AE, Voigt RW, Strauch ED, Sun CC et al (2001) Glypican-3 expression in Wilms tumor and hepatoblastoma. J Pediatr Hematol Oncol 23(8):496–499
8. Gillan TL, Hughes R, Godbout R, Grundy PE (2003) The Simpson-Golabi-Behmel gene, GPC3, is not involved in sporadic Wilms tumorigenesis. Am J Med Genet A 122A(1):30–36
9. Takahashi M, Yang XJ, Sugimura J, Backdahl J, Tretiakova M, Qian CN et al (2003) Molecular subclassification of kidney tumors and the discovery of new diagnostic markers. Oncogene 22(43):6810–6818
10. Baumhoer D, Tornillo L, Stadlmann S, Roncalli M, Diamantis EK, Terracciano LM (2008) Glypican 3 expression in human nonneoplastic, preneoplastic, and neoplastic tissues: a tissue microarray analysis of 4,387 tissue samples. Am J Clin Pathol 129(6):899–906
11. Neri G, Marini R, Cappa M, Borrelli P, Opitz JM (1988) Simpson-Golabi-Behmel syndrome: an X-linked encephalo-tropho-schisis syndrome. Am J Med Genet 30(1–2):287–299
12. Opitz JM, Herrmann J, Gilbert EF, Matalon R (1988) Simpson-Golabi-Behmel syndrome: follow-up of the Michigan family. Am J Med Genet 30(1–2):301–308
13. Veugelers M, Cat BD, Muyldermans SY, Reekmans G, Delande N, Frints S et al (2000) Mutational analysis of the GPC3/GPC4 glypican gene cluster on Xq26 in patients with Simpson-Golabi-Behmel syndrome: identification of loss-of-function mutations in the GPC3 gene. Hum Mol Genet 9(9):1321–1328
14. Li M, Shuman C, Fei YL, Cutiongco E, Bender HA, Stevens C et al (2001) GPC3 mutation analysis in a spectrum of patients with overgrowth expands the phenotype of Simpson-Golabi-Behmel syndrome. Am J Med Genet 102(2):161–168
15. Filmus J (2001) Glypicans in growth control and cancer. Glycobiology 11(3):19R–23R
16. De Cat B, David G (2001) Developmental roles of the glypicans. Semin Cell Dev Biol 12(2):117–125
17. Khan S, Blackburn M, Mao DL, Huber R, Schlessinger D, Fant M (2001) Glypican-3 (GPC3) expression in human placenta: localization to the differentiated syncytiotrophoblast. Histol Histopathol 16(1):71–78
18. Pellegrini M, Pilia G, Pantano S, Lucchini F, Uda M, Fumi M et al (1998) GPC3 expression correlates with the phenotype of the Simpson-Golabi-Behmel syndrome. Dev Dyn 213(4):431–439
19. Midorikawa Y, Ishikawa S, Iwanari H, Imamura T, Sakamoto H, Miyazono K et al (2003) Glypican-3, overexpressed in hepatocellular carcinoma, modulates FGF2 and BMP-7 signaling. Int J Cancer 103(4):455–465
20. Mast AE, Higuchi DA, Huang ZF, Warshawsky I, Schwartz AL, Broze GJ Jr (1997) Glypican-3 is a binding protein on the HepG2 cell surface for tissue factor pathway inhibitor. Biochem J 327(Pt 2):577–583
21. Taguchi A, Emoto M, Okuya S, Fukuda N, Nakamori Y, Miyazaki M et al (2008) Identification of glypican3 as a novel GLUT4-binding protein. Biochem Biophys Res Commun 369(4):1204–1208
22. Song HH, Shi W, Xiang YY, Filmus J (2005) The loss of glypican-3 induces alterations in Wnt signaling. J Biol Chem 280(3):2116–2125
23. Grisaru S, Rosenblum ND (2001) Glypicans and the biology of renal malformations. Pediatr Nephrol 16(3):302–306
24. Cano-Gauci DF, Song HH, Yang H, McKerlie C, Choo B, Shi W et al (1999) Glypican-3-deficient mice exhibit developmental overgrowth and some of the abnormalities typical of Simpson-Golabi-Behmel syndrome. J Cell Biol 146(1):255–264
25. Jain S, Suarez AA, McGuire J, Liapis H (2007) Expression profiles of congenital renal dysplasia reveal new insights into renal development and disease. Pediatr Nephrol 22(7):962–974
26. Lapunzina P, Badia I, Galoppo C, De Matteo E, Silberman P, Tello A et al (1998) A patient with Simpson-Golabi-Behmel syndrome and hepatocellular carcinoma. J Med Genet 35(2):153–156
27. Nakatsura T, Kageshita T, Ito S, Wakamatsu K, Monji M, Ikuta Y et al (2004) Identification of glypican-3 as a novel tumor marker for melanoma. Clin Cancer Res 10(19):6612–6621
28. Charles AK, Brown KW, Berry PJ (1998) Microdissecting the genetic events in nephrogenic rests and Wilms’ tumor development. Am J Pathol 153(3):991–1000
29. Guertl B, Ratschek M, Harms D, Jaenig U, Leuschner I, Poremba C et al (2003) Clonality and loss of heterozygosity of WT genes are early events in the pathogenesis of nephroblastomas. Hum Pathol 34(3):278–281
30. Park S, Bernard A, Bove KE, Sens DA, Hazen-Martin DJ, Garvin AJ et al (1993) Inactivation of WT1 in nephrogenic rests, genetic precursors to Wilms’ tumour. Nat Genet 5(4):363–367
31. Rivera MN, Haber DA (2005) Wilms’ tumour: connecting tumorigenesis and organ development in the kidney. Nat Rev Cancer 5(9):699–712
32. Rodriguez-Criado G, Magano L, Segovia M, Gurrieri F, Neri G, Gonzalez-Meneses A et al (2005) Clinical and molecular studies on two further families with Simpson-Golabi-Behmel syndrome. Am J Med Genet A 138A(3):272–277
33. Chan ES, Pawel BR, Corao DA, Venneti S, Russo P, Santi M et al (2013) Immunohistochemical expression of glypican-3 in pediatric tumors: an analysis of 414 cases. Pediatr Dev Pathol 16(4):272–277
34. Thway K, Selfe J, Missiaglia E, Fisher C, Shipley J (2011) Glypican-3 is expressed in rhabdomyosarcomas but not adult spindle cell and pleomorphic sarcomas. J Clin Pathol 64(7):587–591
35. Zynger DL, Gupta A, Luan C, Chou PM, Yang GY, Yang XJ (2008) Expression of glypican 3 in hepatoblastoma: an immunohistochemical study of 65 cases. Hum Pathol 39(2):224–230
36. Kohashi K, Nakatsura T, Kinoshita Y, Yamamoto H, Yamada Y, Tajiri T et al (2013) Glypican 3 expression in tumors with loss of SMARCB1/INI1 protein expression. Hum Pathol 44(4):526–533
37. Feng M, Gao W, Wang R, Chen W, Man YG, Figg WD et al (2013) Therapeutically targeting glypican-3 via a conformation-specific single-domain antibody in hepatocellular carcinoma. Proc Natl Acad Sci U S A 110(12):E1083–E1091
38. Ikeda M, Ohkawa S, Okusaka T, Mitsunaga S, Kobayashi S, Morizane C et al (2014) Japanese phase I study of GC33, a humanized antibody against glypican-3 for advanced hepatocellular carcinoma. Cancer Sci 105(4):455–462
39. Sawada Y, Yoshikawa T, Fujii S, Mitsunaga S, Nobuoka D, Mizuno S et al (2013) Remarkable tumor lysis in a hepatocellular carcinoma patient immediately following glypican-3-derived peptide vaccination: an autopsy case. Hum Vaccin Immunother 9(6):1228–1233
40. Sawada Y, Yoshikawa T, Nobuoka D, Shirakawa H, Kuronuma T, Motomura Y et al (2012) Phase I trial of a glypican-3-derived peptide vaccine for advanced hepatocellular carcinoma: immunologic evidence and potential for improving overall survival. Clin Cancer Res 18(13):3686–3696
41. Suzuki S, Shibata K, Kikkawa F, Nakatsura T (2014) Significant clinical response of progressive recurrent ovarian clear cell carcinoma to glypican-3-derived peptide vaccine therapy: two case reports. Hum Vaccin Immunother 10(2):338–343
42. Tada Y, Yoshikawa T, Shimomura M, Sawada Y, Sakai M, Shirakawa H et al (2013) Analysis of cytotoxic T lymphocytes from a patient with hepatocellular carcinoma who showed a clinical response to vaccination with a glypican3 derived peptide. Int J Oncol 43(4):1019–1026
43. Zhu AX, Gold PJ, El-Khoueiry AB, Abrams TA, Morikawa H, Ohishi N et al (2013) First-in-man phase I study of GC33, a novel recombinant humanized antibody against glypican-3, in patients with advanced hepatocellular carcinoma. Clin Cancer Res 19(4):920–928
44. Kesik V, Ozcan A, Sari E, Guven A, Kismet E, Koseoglu V (2010) Alpha-fetoprotein producing tumor cells in children with Wilms’ tumor. Fetal Pediatr Pathol 29(3):127–132